As the global pharmaceutical industry steers into a phase defined by innovation, advanced manufacturing, automation, and deeper collaboration, CPHI and PMEC India 2026 has announced a milestone expansion that reflects the growing scale, ambition, and evolution of India’s pharmaceutical ecosystem.
Entering its 19th edition, the platform will be hosted across two world-class venues in Delhi-NCR, enabling sharper focus and deeper engagement at scale. CPHI India will take place from 23–25 November 2026 at IICC, Yashobhoomi, New Delhi, while PMEC India will be organised from 24–26 November 2026 at India Expo Mart, Greater Noida. The partially overlapping schedules create a continuous four-day engagement window, offering greater flexibility and expanded opportunities for collaboration across the pharmaceutical value chain.
For nearly two decades, CPHI and PMEC India have been recognized as the ‘Heart of Pharma’ in the country, bringing together domestic and international stakeholders to connect, collaborate, and grow. The expanded format marks the next chapter of this legacy—aligned with an industry that is increasingly specialized, technology-enabled, and outcome-driven.
India’s role in global pharma
India continues to strengthen its position as one of the world’s most important pharmaceutical hubs. As the third-largest pharmaceutical producer by volume, the country supplies over 20% of global generic medicines while steadily expanding its footprint across APIs, finished dosage formulations, contract manufacturing, biotechnology, and advanced therapies. With the Indian pharmaceutical market projected to reach approximately USD 130 billion by 2030, the industry is entering a phase of sustained growth and heightened global relevance.
At the same time, the sector is advancing rapidly through digitization, AI-led manufacturing and quality systems, creating new opportunities to enhance efficiency, compliance, and innovation. As regulatory expectations rise globally and supply chains become increasingly interconnected, the need for focused, high-quality industry engagement has become more important than ever.
As the shows grew alongside this momentum, increasing scale and diversity of participation created the need for a format that could deliver greater clarity, depth, and relevance.
Speaking on the expansion of the platform, Yogesh Mudras, managing director, Informa Markets in India, says: “The decision to expand CPHI & PMEC India into a two-venue format was driven by research and clear industry feedback. After an 18-month international, consultant-led study and extensive stakeholder consultations, it was evident that the platform had outgrown a single venue. Visitors needed more time, exhibitors needed more space, and both were seeking deeper, more effective engagement. The overlapping schedule effectively adds a fourth day, improving time efficiency, enabling cross-show synergy, and delivering stronger ROI.
By removing size constraints and creating focused, specialized platforms, we are enabling innovation across the entire pharmaceutical value chain while continuing to deliver the trust, continuity, and value the industry expects from us. This expansion is about building a future-ready platform that supports India’s growing leadership as the pharmacy of the world,” he added.
CPHI India: The Hub for ingredients, APIs, formulations and services
Hosted at Yashobhoomi, New Delhi, CPHI India 2026 will continue to serve as India’s most internationally connected platform for pharmaceutical ingredients, APIs, formulations, and associated services. The platform will bring together API and excipient manufacturers, generic and finished dosage producers, CROs, CDMOs, biotech organizations, and service providers, supporting global sourcing, export-led growth, innovation exchange, and strategic partnerships.
With clearer segmentation and structured exhibition zones, CPHI India is designed to enable deeper engagement across commercial, technical, regulatory, and R&D-led conversations that underpin global pharmaceutical supply chains.
PMEC India: Pharmaceutical manufacturing and technology
At India Expo Mart, Greater Noida, PMEC India 2026 will evolve into a fully dedicated destination for pharmaceutical machinery, equipment, and manufacturing technologies. With an exclusive focus on processing, packaging, cleanroom, laboratory, automation, and digitally enabled manufacturing solutions, PMEC India offers a highly immersive environment for engineering, manufacturing, and operations decision-makers.
This sharper focus reinforces India’s growing capabilities in pharmaceutical manufacturing and technology, supporting the broader Make in India vision for pharma machinery and strengthening the country’s role as a global manufacturing and sourcing partner.
One unified ecosystem
Together, CPHI India and PMEC India represent the complete pharmaceutical value chain, delivered through two specialized yet seamlessly connected platforms. The format enhances navigability, relevance, and engagement quality, ensuring that each segment receives the environment it needs while enabling synergistic interaction across formulation, ingredients, and manufacturing communities.
Thoughtfully curated features such as a single registration providing real-time access to both venues, dedicated shuttle services, Delhi Metro connectivity, and an enhanced digital platform are designed to help participants plan meetings and optimize their time on-site.
Apart from the business on the show floor, the expanded format has been designed to deliver value and dynamism through its emphasis on leadership dialogue, curated networking, and community-building initiatives, including Women in Pharma, leadership roundtables, more structured exhibition zones, and expanded international participation.
Rahul Deshpande, senior group director, Informa Markets in India, says, “This expansion strengthens the pharmaceutical ecosystem by giving both CPHI India and PMEC India the focus and scale they need to grow, while remaining part of one integrated value-chain platform. CPHI continues as the global hub for APIs, formulations, and services, while PMEC now has a fully dedicated venue to showcase machinery and manufacturing technologies at a much larger and more impactful scale.
For exhibitors, the priorities are clear—business generation, relevant buyers, and meaningful conversations—and this new format delivers exactly that. With overlapping days, participants gain exposure across the value chain in ways that were not possible earlier. Indeed, if you are in pharma and not at CPHI & PMEC, you are genuinely missing something big,” he added.
For nearly 19 years, CPHI & PMEC India have been where the pharmaceutical industry comes together to connect, collaborate, and move forward. As global pharma enters its next phase of growth and innovation, CPHI & PMEC India 2026 stands ready to play a central role—bringing the industry together at bigger scale, with better experience, and with dedicated spaces for focused business.
